AZ Lab Life Sciences Law Firm - Washington, DC

AZ Lab Life Sciences Law Firm is a boutique law firm that provides U.S.-China life sciences regulatory, compliance, and transactional services. We are specialized in advising companies and scientists on regulatory strategies and bringing their most-promising therapeutics to the market in the U.S. and China. We help companies and scientists resolve regulatory issues before the U.S. Food and Drug Administration (FDA) and China National Medical Product Administration (NMPA) and advise on conducting clinical trials, use of foreign clinical trial data, obtaining marketing approvals, regulatory exclusivities, orphan drugs, promotion, post-market compliance, manufacturing and related issues during the life cycle of medical products in the U.S. and China. We regularly conduct life sciences due diligence, represent companies in negotiating and drafting a suite of agreements such as life sciences licensing and collaboration agreements, asset purchase agreements, clinical trial agreements, expanded access agreements, manufacturing and quality agreements, pharmacovigilance agreements and other commercial agreements, and have experience in venture capital investment and corporate transactions both in the U.S. and China.

Led by an experienced bilingual lawyer who has more than ten years’ experience in the U.S. FDA and China NMPA regulatory field and is well acquainted with the Chinese and the U.S. legal, business and cultural environment, AZ Lab aims to provide a full range of legal solutions to you from when you have the first breakthrough discovery in the lab to marketing your potential therapeutics in the U.S. and China.